Roles and regulatory mechanisms of KIN17 in cancers (Review)

KIN17, which is known as a DNA and RNA binding protein, is highly expressed in numerous types of human cancers and was discovered to participate in several vital cell behaviors, including DNA replication, damage repair, regulation of cell cycle and RNA processing. Furthermore, KIN17 is associated with cancer cell proliferation, migration, invasion and cell cycle regulation by regulating pathways including the p38 MAPK, NF-κB-Snail and TGF-β/Smad2 signaling pathways. In addition, knockdown of KIN17 was found to enhance the sensitivity of tumor cells to chemotherapeutic agents. Immunohistochemical analysis revealed that there were significant differences in the expression of KIN17 between cancer tissues and adjacent tissues. Both the Kaplan-Meier survival analysis and multivariate Cox regression analysis indicated that KIN17 is aberrantly high expressed in various tumor tissues and is also associated with poor prognosis in patients with various tumor types. Taken together, KIN17 has key roles in tumorigenesis and cancer development. Investigating the relationship between KIN17 and neoplasms will provide a vital theoretical basis for KIN17 to serve as a diagnostic and prognostic biomarker for cancer patients and as a potential target for cancer therapy.

[1]  Tiancai Liu,et al.  KIN17 promotes cell migration and invasion through stimulating the TGF‐β/Smad2 pathway in hepatocellular carcinoma , 2022, Molecular carcinogenesis.

[2]  T. Zeng,et al.  Deficiency of kin17 Facilitates Apoptosis of Cervical Cancer Cells by Modulating Caspase 3, PARP, and Bcl-2 Family Proteins , 2022, Journal of oncology.

[3]  J. Qi,et al.  Exploring Methods of Targeting Histone Methyltransferases and Their Applications in Cancer Therapeutics. , 2022, ACS chemical biology.

[4]  B. Coulombe,et al.  Interactome Analysis of KIN (Kin17) Shows New Functions of This Protein , 2021, Current issues in molecular biology.

[5]  Huafeng Zhang,et al.  Metabolic reprogramming and epigenetic modifications on the path to cancer , 2021, Protein & Cell.

[6]  T. Zeng,et al.  KIN17 promotes tumor metastasis by activating EMT signaling in luminal‐A breast cancer , 2021, Thoracic cancer.

[7]  Wei Liu,et al.  Analysis of the association between KIN17 expression and the clinical features/prognosis of epithelial ovarian cancer, and the effects of KIN17 in SKOV3 cells , 2021, Oncology letters.

[8]  Yin Tang,et al.  Overview of Histone Modification. , 2021, Advances in experimental medicine and biology.

[9]  Mingzhi Zhang,et al.  Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma , 2020, Clinical Epigenetics.

[10]  C. Zhu,et al.  Kin17 knockdown suppresses the migration and invasion of cervical cancer cells through NF-κB-Snail pathway. , 2020, International journal of clinical and experimental pathology.

[11]  Í. Caruso,et al.  Biophysical characterization and molecular phylogeny of human KIN protein , 2019, European Biophysics Journal.

[12]  V. Treviño.  Integrative genomic analysis identifies associations of molecular alterations to APOBEC and BRCA1/2 mutational signatures in breast cancer , 2019, Molecular genetics & genomic medicine.

[13]  Jeung-Whan Han,et al.  Targeting epigenetics for cancer therapy , 2019, Archives of Pharmacal Research.

[14]  Xiang Gao,et al.  Knockdown of DNA/RNA-binding protein KIN17 promotes apoptosis of triple-negative breast cancer cells , 2018, Oncology letters.

[15]  K. Miller,et al.  Histone methylation and the DNA damage response. , 2017, Mutation research.

[16]  Haitao Zhang,et al.  Relationships of kin17 protein expression with clinical features and prognosis of colorectal cancer , 2018, Translational Cancer Research.

[17]  M. Luo.  Chemical and Biochemical Perspectives of Protein Lysine Methylation. , 2018, Chemical reviews.

[18]  J. Vadgama,et al.  Optimization Of Cancer Treatment Through Overcoming Drug Resistance , 2018, Journal of cancer research and oncobiology.

[19]  Weiwei Yang,et al.  Distinct functions of histone H3, lysine 4 methyltransferases in normal and malignant hematopoiesis , 2017, Current opinion in hematology.

[20]  Xiang Gao,et al.  Elevated Expression of Kin17 in Cervical Cancer and Its Association With Cancer Cell Proliferation and Invasion , 2017, International Journal of Gynecologic Cancer.

[21]  Devin K. Schweppe,et al.  Architecture of the human interactome defines protein communities and disease networks , 2017, Nature.

[22]  Kihyun Park,et al.  Writing, erasing and reading histone lysine methylations , 2017, Experimental &Molecular Medicine.

[23]  T. Zeng,et al.  Upregulation of KIN17 is associated with non-small cell lung cancer invasiveness , 2017, Oncology letters.

[24]  Sebastian A. Leidel,et al.  The novel lysine specific methyltransferase METTL21B affects mRNA translation through inducible and dynamic methylation of Lys-165 in human eukaryotic elongation factor 1 alpha (eEF1A) , 2017, Nucleic acids research.

[25]  J. Moffat,et al.  Kin17 facilitates multiple double-strand break repair pathways that govern B cell class switching , 2016, Scientific Reports.

[26]  Peter A. Jones,et al.  Targeting the cancer epigenome for therapy , 2016, Nature Reviews Genetics.

[27]  M. Nakanishi,et al.  Defective DNA repair increases susceptibility to senescence through extension of Chk1-mediated G2 checkpoint activation , 2016, Scientific Reports.

[28]  Ebru Ortaç Ersoy,et al.  [Lung cancer and epigenetic modifications]. , 2016, Tuberkuloz ve toraks.

[29]  A. Klungland,et al.  Lysine Methylation of the Valosin-Containing Protein (VCP) Is Dispensable for Development and Survival of Mice , 2015, PloS one.

[30]  Anton Simeonov,et al.  Cell-based assays to support the profiling of small molecules with histone methyltransferase and demethylase modulatory activity. , 2015, Drug discovery today. Technologies.

[31]  M. A. Fernandez,et al.  The kin17 Protein in Murine Melanoma Cells , 2015, International journal of molecular sciences.

[32]  William M. Grady,et al.  Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers. , 2015, Gastroenterology.

[33]  E. Davydova,et al.  Saccharomyces cerevisiae Eukaryotic Elongation Factor 1A (eEF1A) Is Methylated at Lys-390 by a METTL21-Like Methyltransferase , 2015, PloS one.

[34]  Chao Xu,et al.  Epigenetic targets and drug discovery: part 1: histone methylation. , 2014, Pharmacology & therapeutics.

[35]  M. Blanchette,et al.  Methylation of the DNA/RNA-binding protein Kin17 by METTL22 affects its association with chromatin. , 2014, Journal of proteomics.

[36]  Hiroshi Kimura,et al.  Histone modifications for human epigenome analysis , 2013, Journal of Human Genetics.

[37]  M. Blanchette,et al.  A Newly Uncovered Group of Distantly Related Lysine Methyltransferases Preferentially Interact with Molecular Chaperones to Regulate Their Activity , 2013, PLoS genetics.

[38]  Arun S. Seetharam,et al.  A study on the distribution of 37 well conserved families of C2H2 zinc finger genes in eukaryotes , 2013, BMC Genomics.

[39]  M. Dawson,et al.  Cancer Epigenetics: From Mechanism to Therapy , 2012, Cell.

[40]  O. Kovalchuk,et al.  Epigenetics in Health and Disease , 2012 .

[41]  Naina Phadnis,et al.  New and old ways to control meiotic recombination. , 2011, Trends in genetics : TIG.

[42]  T. Zeng,et al.  Up-Regulation of Kin17 Is Essential for Proliferation of Breast Cancer , 2011, PloS one.

[43]  E. Wagner,et al.  EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer , 2008, Nature Cell Biology.

[44]  S. Zinn-Justin,et al.  Solution structure of the region 51–160 of human KIN17 reveals an atypical winged helix domain , 2007, Protein science : a publication of the Protein Society.

[45]  D. Biard,et al.  Untangling the relationships between DNA repair pathways by silencing more than 20 DNA repair genes in human stable clones , 2007, Nucleic acids research.

[46]  C. Sotiriou,et al.  Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients , 2007, British Journal of Cancer.

[47]  M. Esteller.  Cancer epigenomics: DNA methylomes and histone-modification maps , 2007, Nature Reviews Genetics.

[48]  S. Zinn-Justin,et al.  A tandem of SH3-like domains participates in RNA binding in KIN17, a human protein activated in response to genotoxics. , 2006, Journal of molecular biology.

[49]  M. Toyota,et al.  [Epigenetic alterations in cancer]. , 2006, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[50]  G. Maga,et al.  The Human Stress-Activated Protein kin17 Belongs to the Multiprotein DNA Replication Complex and Associates In Vivo with Mammalian Replication Origins , 2005, Molecular and Cellular Biology.

[51]  P. Chartrand,et al.  KIN17, a mouse nuclear protein, binds to bent DNA fragments that are found at illegitimate recombination junctions in mammalian cells , 1994, Molecular and General Genetics MGG.

[52]  R. Trievel.  Structure and function of histone methyltransferases. , 2004, Critical reviews in eukaryotic gene expression.

[53]  G. Maga,et al.  Selective interactions of human kin17 and RPA proteins with chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner. , 2003, Nucleic acids research.

[54]  D. Biard,et al.  Depletion of KIN17, a Human DNA Replication Protein, Increases the Radiosensitivity of RKO Cells , 2003, Radiation research.

[55]  D. Biard,et al.  Participation of kin17 protein in replication factories and in other DNA transactions mediated by high molecular weight nuclear complexes. , 2003, Molecular cancer research : MCR.

[56]  A. Sarasin,et al.  Global genome repair is required to activate KIN17, a UVC-responsive gene involved in DNA replication , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[57]  D. Biard,et al.  Human kin17 protein directly interacts with the simian virus 40 large T antigen and inhibits DNA replication. , 2002, Cancer research.

[58]  D. Biard,et al.  Ionizing Radiation Triggers Chromatin-bound kin17 Complex Formation in Human Cells* , 2002, The Journal of Biological Chemistry.

[59]  F. Menaa,et al.  Identification of KIN (KIN17), a Human Gene Encoding a Nuclear DNA-Binding Protein, as a Novel Component of the TP53-Independent Response to Ionizing Radiation , 2001, Radiation research.

[60]  P. Herrlich,et al.  UV-Induced Stabilization of c-fos and Other Short-Lived mRNAs , 2000, Molecular and Cellular Biology.

[61]  A. Agarwal,et al.  Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3'-kinase and phospholipase C-dependent mechanism. , 1999, Cancer research.

[62]  A. Sarasin,et al.  The nuclear concentration of kin17, a mouse protein that binds to curved DNA, increases during cell proliferation and after UV irradiation. , 1998, Carcinogenesis.

[63]  M. Maratrat,et al.  Enhanced expression of the Kin17 protein immediately after low doses of ionizing radiation. , 1997, Radiation research.

[64]  P. Mauffrey,et al.  Molecular cloning and characterization of the mouse Kin17 gene coding for a Zn-finger protein that preferentially recognizes bent DNA. , 1996, Genomics.

[65]  P. Mauffrey,et al.  The mouse Kin-17 gene codes for a new protein involved in DNA transactions and is akin to the bacterial RecA protein. , 1995, Biochimie.

[66]  V. Schreiber,et al.  Kin17, a mouse nuclear zinc finger protein that binds preferentially to curved DNA. , 1994, Nucleic acids research.

[67]  R. Benarous,et al.  Identification of a mouse cDNA fragment whose expressed polypeptide reacts with anti-recA antibodies. , 1991, Biochimie.

[68]  J. Angulo,et al.  KIN, a mammalian nuclear protein immunologically related to E. coli RecA protein. , 1989, Mutation research.